Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback